Emcure Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Emcure Pharmaceuticals Ltd. on BSE

Load latest

Emcure Pharmaceuticals Ltd.

21 Jun 2025

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Intimation of proposed incorporation of a Wholly-owned subsidiary by the name "Emcure Wellness Private Limited"

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Acquisition of Equity Shares, constituting 20.42% of the total issued and paid-up capital of Zuventus Healthcare Limited, a subsidiary of the Company, thereby making Zuventus a wholly-owned subsidiary of the Company.

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025

1372.70

0.15%

Corp. Note

Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting held on June 21, 2025

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Outcome Of Board Meeting Held On June 21, 2025

BSE India

Outcome of Board Meeting held on June 21, 2025

pdf

Emcure Pharmaceuticals Ltd.

19 Jun 2025

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 31A Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of requests from members of the Promoter and Promoter Group of the Company, seeking re-classification from the ''Promoter and Promoter Group'' category to ''Public'' category.

pdf

Emcure Pharmaceuticals Ltd.

18 Jun 2025

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of schedule of Analyst/ Investor Meeting(s) to be held on Monday, June 23, 2025 & Tuesday, June 24, 2025

pdf

Emcure Pharmaceuticals Ltd.

18 Jun 2025

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of schedule of Analyst/ Investor Meeting(s) to be held on Monday, June 23, 2025 & Tuesday, June 24, 2025

pdf

Emcure Pharmaceuticals Ltd.

17 Jun 2025

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Incorporation of a Wholly-owned Subsidiary of the Company with name "Emcure Lifesciences Private Limited".

pdf

Emcure Pharmaceuticals Ltd.

12 Jun 2025

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Intimation under Regulation 30 of SEBI Listing Regulations, 2015, for allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure - Employee Stock Option Scheme 2013

pdf

Emcure Pharmaceuticals Ltd.

03 Jun 2025, 07:23PM

1372.70

0.15%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Resignation of Senior Management Personnel of the Company.

pdf